{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:05:17Z","timestamp":1787580317291,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.rcsop.2024.100414","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T13:07:07Z","timestamp":1706620027000},"page":"100414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of a Community Pharmacy Pharmacotherapy Follow-up (PTF) service in patients using opioid analgesic"],"prefix":"10.1016","volume":"13","author":[{"given":"V.","family":"Hern\u00e1ndez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rubio-Armend\u00e1riz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Alberto-Armas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hardisson-de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2024.100414_bb0220","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Vos","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.rcsop.2024.100414_bib237","series-title":"Asuntos Sociales e Igualdad. Documento Marco para la mejora del abordaje del dolor en el SNS","author":"Ministerios de Sanidad","year":"2014"},{"issue":"36","key":"10.1016\/j.rcsop.2024.100414_bb0065","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","article-title":"Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016","volume":"67","author":"Dahlhamer","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100414_bb0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1403494820987466","article-title":"The gender pain gap: gender inequalities in pain across 19 European countries","volume":"50","author":"Bimpong","year":"2022","journal-title":"Scand J Public Health"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100414_bib235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4321\/S1134-80462014000100003","article-title":"Situaci\u00f3n actual del dolor cr\u00f3nico en Espa\u00f1a: iniciativa \u201cPain Proposal","volume":"21","author":"Torralba","year":"2014","journal-title":"Rev Soc Esp Dolor"},{"issue":"12","key":"10.1016\/j.rcsop.2024.100414_bb0085","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1016\/j.sapharm.2022.07.043","article-title":"Opioid deprescribing: qualitative perspectives from those with chronic non-cancer pain","volume":"18","author":"Hamilton","year":"2022","journal-title":"Res Social Adm Pharm"},{"issue":"6","key":"10.1016\/j.rcsop.2024.100414_bb0060","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/bja\/aei145","article-title":"Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats","volume":"94","author":"Dahan","year":"2005","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.rcsop.2024.100414_bib234","series-title":"Foro de Atenci\u00f3n Farmac\u00e9utica-Farmacia Comunitaria (Foro AF-FC). Gu\u00eda pr\u00e1ctica para los Servicios Profesionales Farmac\u00e9uticos Asistenciales en la Farmacia Comunitaria","author":"Foro","year":"2019"},{"key":"10.1016\/j.rcsop.2024.100414_bb0205","author":"The PCNE"},{"key":"10.1016\/j.rcsop.2024.100414_bb0225","series-title":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","author":"WHO","year":"2009"},{"key":"10.1016\/j.rcsop.2024.100414_bb0230","series-title":"Cancer pain relief, with a guide to opioid availability","author":"World Health Organization (WHO)","year":"1996"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100414_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.sapharm.2015.05.001","article-title":"Developing a framework of care for opioid medication misuse in community pharmacy","volume":"12","author":"Cochran","year":"2016","journal-title":"Res Social Adm Pharm"},{"issue":"3","key":"10.1016\/j.rcsop.2024.100414_bb0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.semperi.2019.01.001","article-title":"The United States opioid epidemic","volume":"43","author":"Lyden","year":"2019","journal-title":"Semin Perinatol"},{"issue":"5","key":"10.1016\/j.rcsop.2024.100414_bb0080","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.sapharm.2021.06.018","article-title":"The role of pharmacists in opioid stewardship: a scoping review","volume":"18","author":"Gondora","year":"2022","journal-title":"Res Soc Admin Pharm"},{"key":"10.1016\/j.rcsop.2024.100414_bb0130","first-page":"S67","article-title":"American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2 \u2013 guidance","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100414_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.rcsop.2024.100414_bb0200","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.sapharm.2021.07.023","article-title":"Pharmacists opioid risk and safety counseling practices: a latent class analysis approach","volume":"18","author":"Thakur","year":"2022","journal-title":"Res Social Adm Pharm"},{"issue":"12","key":"10.1016\/j.rcsop.2024.100414_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278992","article-title":"Determinants of long-term opioid use in hospitalized patients","volume":"17","author":"Kurteva","year":"2022","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100414_bb0180","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12871-021-01501-8","article-title":"Perspectives of pain specialists, patients, and family members on long-term opioid use for chronic non-cancer pain: a qualitative study","volume":"21","author":"Seangrung","year":"2021","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100414_bb0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1715163517745517","article-title":"Pharmacists as accessible primary health care providers: review of the evidence","volume":"151","author":"Tsuyuki","year":"2018","journal-title":"Can Pharm J.(Ott)."},{"issue":"1","key":"10.1016\/j.rcsop.2024.100414_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"10.1016\/j.rcsop.2024.100414_bib233","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1016\/j.sapharm.2022.03.005","article-title":"Economic impact of pharmaceutical services on polymedicated patients: A systematic review","volume":"18","author":"Bezerra","year":"2022","journal-title":"Res Soc Administrative Pharm"},{"issue":"3","key":"10.1016\/j.rcsop.2024.100414_bb0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1077558712459215","article-title":"The effect of community pharmacy-based interventions on patient health outcomes: a systematic review","volume":"70","author":"Blalock","year":"2013","journal-title":"Med Care Res Rev"},{"key":"10.1016\/j.rcsop.2024.100414_bb0050","series-title":"Pharmaceutical care practice","author":"Cipolle","year":"1998"},{"issue":"3","key":"10.1016\/j.rcsop.2024.100414_bb0210","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.sapharm.2022.10.007","article-title":"Community pharmacy and primary health care \u2013 types of integration and their applicability: a narrative review","volume":"19","author":"Urionag\u00fcena","year":"2023","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2024.100414_bb0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pain.2007.06.018","article-title":"A systematic review of the effect of waiting for treatment for chronic pain","volume":"136","author":"Lynch","year":"2008","journal-title":"Pain."},{"issue":"4","key":"10.1016\/j.rcsop.2024.100414_bb0100","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.sapharm.2021.05.015","article-title":"A systematic review of community pharmacy initiatives to improve treatment of depression and pain: focus on types of programs and patient-reported outcomes","volume":"18","author":"Karp","year":"2022","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100414_bb0215","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.sapharm.2022.12.009","article-title":"Identifying health outcomes of pharmaceutical clinical services in patients with cancer: a systematic review","volume":"19","author":"Valen\u00e7a-Feitosa","year":"2023","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100414_bb0090","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.sapharm.2022.12.002","article-title":"A community pharmacy practice-based research network: a protocol for a realist evaluation","volume":"19","author":"Handyside","year":"2023","journal-title":"Res Social Adm Pharm"},{"issue":"10","key":"10.1016\/j.rcsop.2024.100414_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3928\/00989134-20170523-01","article-title":"Medication adherence interventions for older adults with heart failure: a systematic review","volume":"43","author":"Andrews","year":"2017","journal-title":"J Gerontol Nurs"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100414_bb0095","first-page":"104","article-title":"Risk indicators in fentanyl use: opportunities to improve outcomes with a personal pharmaceutical care approach in community pharmacies","volume":"9","author":"Hern\u00e1ndez","year":"2021","journal-title":"EC Pharmacol Toxicol"},{"issue":"7","key":"10.1016\/j.rcsop.2024.100414_bb0190","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"suppl 11","key":"10.1016\/j.rcsop.2024.100414_bb0160","first-page":"S276","article-title":"Opioid pharmacokinetic drug-drug interactions","volume":"17","author":"Overholser","year":"2011","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100414_bb0135","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11606-017-4199-3","article-title":"Cultural issues in medication adherence: disparities and directions","volume":"33","author":"McQuaid","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100414_bb0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.amjms.2016.01.010","article-title":"Medication adherence: truth and consequences","volume":"351","author":"Brown","year":"2016","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100414_bb0035","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.sapharm.2021.05.003","article-title":"A pharmacist\u2019s unique opportunity within a multidisciplinary team to reduce drug-related problems for older adults in an intermediate care setting","volume":"18","author":"Byrne","year":"2022","journal-title":"Res Social Adm Pharm"},{"issue":"3","key":"10.1016\/j.rcsop.2024.100414_bib232","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/bcp.12995","article-title":"Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community-dwelling older people: a prospective cohort study","volume":"82","author":"Moriarty","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.rcsop.2024.100414_bib231","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1016\/j.sapharm.2022.06.005","article-title":"Drug-related problems and satisfaction among patients receiving pharmacist-led consultations at the initiation of cardiovascular drugs","volume":"18","author":"Bremer","year":"2022","journal-title":"Res Soc Administrative Pharm"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266727662400009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266727662400009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:32:41Z","timestamp":1757406761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266727662400009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":38,"alternative-id":["S266727662400009X"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2024.100414","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of a Community Pharmacy Pharmacotherapy Follow-up (PTF) service in patients using opioid analgesic","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2024.100414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100414"}}